Skip Navigation LinksHome > March 2014 - Volume 74 - Issue 3 > Percutaneous Stereotactic Radiofrequency Lesioning for Trige...
Neurosurgery:
doi: 10.1227/NEU.0000000000000262
Research-Human-Clinical Studies: Editor's Choice

Percutaneous Stereotactic Radiofrequency Lesioning for Trigeminal Neuralgia: Determination of Minimum Clinically Important Difference in Pain Improvement for Patient-Reported Outcomes

Reddy, Vishruth K. BA*; Parker, Scott L. MD*; Lockney, Dennis T. MD*; Patrawala, Samit A. MD*; Su, Pei-Fang PhD‡,§; Mericle, Robert A. MD

Editor's Choice
Collapse Box

Abstract

BACKGROUND: The Visual Analog Scale (VAS) and the Barrow Neurological Institute Pain Scale (BNI-PS) are 2 patient-reported outcome (PRO) tools frequently used to rate pain from trigeminal neuralgia (TN). Outcomes studies often use these patient-reported outcomes to assess treatment effectiveness, but it is unknown exactly what degree of change in the numerical scores constitutes the minimum clinically important difference (MCID). MCID remains uninvestigated for percutaneous stereotactic radiofrequency lesioning (RFL), a common surgical procedure for TN.

OBJECTIVE: To determine MCID values for the VAS and BNI-PS in patients undergoing RFL.

METHODS: Forty-three consecutive patients with TN who underwent RFL by a single surgeon were prospectively assessed with the VAS and BNI-PS preoperatively and 3 years postoperatively. Three anchors were used to assign each patient’s outcome: satisfaction, willingness to have the surgery again, and Health Transition Index. We then used 3 well-established, anchor-based methods to calculate MCID: average change, minimum detectable change, and change difference.

RESULTS: Patients experienced substantial improvement in both VAS (9.81 vs 3.35; P < .001) and BNI-PS (4.95 vs 2.44; P < .001) after RFL. The 3 MCID calculation methods generated a range of MCID values for each of the PROs (VAS, 4.13-8.20; BNI-PS, 1.03-3.30). The area under the receiver-operating characteristic curve was greater for BNI-PS compared with VAS for all 3 anchors, indicating that BNI-PS is probably better suited for calculating MCID.

CONCLUSION: RFL-specific MCID is variable on the basis of the calculation technique. With the use of the minimum detectable change calculation method with the Health Transition Index anchor, the minimum clinically important difference is 4.49 for VAS and 1.16 for BNI-PS after RFL for TN.

ABBREVIATIONS: AUC, area under the receiver-operating characteristic curve

BNI-PS, Barrow Neurological Institute Pain Scale

HTI, Health Transition Index

MCID, minimum clinically important difference

MDC, minimum detectable change

PRO, patient-reported outcome

RFL, percutaneous stereotactic radiofrequency lesioning

TN, trigeminal neuralgia

VAS, Visual Analog Scale

Copyright © by the Congress of Neurological Surgeons

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.